종합 대사 패널(CMP) 검사 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

Comprehensive Metabolic Panel Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

US $ 5,795 ￦ 8,352,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795 ￦ 12,676,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795 ￦ 17,000,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

종합 대사 패널(CMP) 검사 시장 - 조사 범위

TMR의 조사 보고서 "세계의 종합 대사 패널(CMP) 검사 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2024년을 기준연도로, 2034년을 예측 연도로 하여 2018년부터 2034년까지 세계 종합 대사 패널(CMP) 검사 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 종합 대사 패널(CMP) 검사 시장의 복합 연간 성장률(CAGR%)을 제시합니다.

이 보고서는 광범위한 조사 조사를 통해 작성되었으며, 1차 조사에서는 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 언론 보도 및 관련 문서를 참조하여 종합적인 대사 패널(CMP) 검사 시장을 이해했습니다. 보도자료, 관련 문서를 참고하였습니다.

시장 현황
2023년 시장 규모	110억 달러
2034년 시장 규모	185억 달러
CAGR	4.8%

이 보고서는 세계 종합 대사 패널(CMP) 검사 시장의 경쟁 환경을 조사했습니다. 세계 종합 대사 패널(CMP) 검사 시장에서 활동하는 주요 기업을 식별하고 각 기업의 다양한 속성에 따라 프로파일을 작성했습니다. 기업 개요, 재무 상태, 최근 동향, SWOT는 이 보고서에서 다루는 세계 종합 대사 패널(CMP) 검사 시장 기업의 속성입니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 시장

제4장 시장 개요

• 서론
• 개요
• 시장 역학
• 시장 분석과 예측, 2020-2034년

제5장 주요 인사이트

• 파이프라인 분석
• 주요 제품 및 브랜드 분석
• 주요 M&A
• COVID-19의 산업에 대한 영향

제6장 세계 시장 분석과 예측 : 검사 유형별

• 서론과 정의
• 주요 조사 결과와 발전
• 시장 매출 예측 : 검사 유형별, 2020-2034년
  • 글루코오스
  • 칼슘
  • 전해질
  • 신장기능 검사
  • 간기능 검사
  • 기타(단백질 등)
• 시장의 매력 분석 : 검사 유형별

제7장 세계 시장 분석과 예측 : 적응 질환별

• 서론과 정의
• 주요 조사 결과와 발전
• 시장 매출 예측 : 적응 질환별, 2020-2034년
  • 신장질환
  • 간질환
  • 당뇨병
  • 기타(고혈압 등)
• 시장의 매력 분석 : 적응 질환별

제8장 세계 시장 분석과 예측 : 최종사용자별

• 서론과 정의
• 주요 조사 결과와 발전
• 시장 매출 예측 : 최종사용자별, 2020-2034년
  • 병원 및 클리닉
  • 진단 실험실
  • 기타(연구기관 등)
• 시장의 매력 분석 : 최종사용자별

제9장 세계 시장 분석과 예측 : 지역별

• 주요 조사 결과
• 시장 매출 예측 : 지역별, 2020-2034년
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제10장 북미 시장 분석과 예측

제11장 유럽 시장 분석과 예측

제12장 아시아태평양 시장 분석과 예측

제13장 라틴아메리카 시장 분석과 예측

제14장 중동 및 아프리카 시장 분석과 예측

제15장 경쟁 구도

• 시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
• 시장 점유율 분석 : 기업별(2023년)
• 기업 개요
  • Roche Diagnostics
  • Scion Lab Services, LLC
  • Baptist Health
  • Walk-in Lab, LLC
  • Testing.com
  • My Care Labs
  • ARUP Laboratories
  • Blueprint Genetics Oy
  • Applied InGENuity Diagnostics
  • Quest Diagnostics

LSH

영문 목차

영문목차

Comprehensive Metabolic Panel (CMP) Testing Market - Scope of Report

TMR's report on the global comprehensive metabolic panel (CMP) testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global comprehensive metabolic panel (CMP) testing market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global comprehensive metabolic panel (CMP) testing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the comprehensive metabolic panel (CMP) testing market.

Market Snapshot
Market Value in 2023	US$ 11 Bn
Market Value in 2034	US$ 18.5 Bn
CAGR	4.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global comprehensive metabolic panel (CMP) testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global comprehensive metabolic panel (CMP) testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global comprehensive metabolic panel (CMP) testing market.

The report delves into the competitive landscape of the global comprehensive metabolic panel (CMP) testing market. Key players operating in the global comprehensive metabolic panel (CMP) testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global comprehensive metabolic panel (CMP) testing market profiled in this report.

Key Questions Answered in Global comprehensive metabolic panel (CMP) testing Market Report:

• What is the sales/revenue generated by comprehensive metabolic panel (CMP) testing across all regions during the forecast period?
• What are the opportunities in the global comprehensive metabolic panel (CMP) testing market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Comprehensive Metabolic Panel (CMP) Testing Market - Research Objectives and Research Approach

The comprehensive report on the global comprehensive metabolic panel (CMP) testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global comprehensive metabolic panel (CMP) testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global comprehensive metabolic panel (CMP) testing market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Comprehensive Metabolic Panel (CMP) Testing Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Product Definition
  • 4.1.2. Industry Evolution/Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, 2020-2034

5. Key Insights

• 5.1. Pipeline Analysis
• 5.2. Key Product /Brand Analysis
• 5.3. Key Mergers & Acquisitions
• 5.4. COVID-19 Pandemic Impact on Industry

6. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by Test Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Test Type, 2020-2034
  • 6.3.1. Glucose
  • 6.3.2. Calcium
  • 6.3.3. Electrolytes
  • 6.3.4. Kidney Function Tests
  • 6.3.5. Liver Function Tests
  • 6.3.6. Others (Protein, etc.)
• 6.4. Market Attractiveness Analysis, by Test Type

7. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by Disease Indication

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Disease Indication, 2020-2034
  • 7.3.1. Kidney Diseases
  • 7.3.2. Liver Diseases
  • 7.3.3. Diabetes
  • 7.3.4. Others (Hypertension, etc.)
• 7.4. Market Attractiveness Analysis, by Disease Indication

8. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by End-user, 2020-2034
  • 8.3.1. Hospitals & Clinics
  • 8.3.2. Diagnostic Laboratories
  • 8.3.3. Others (Research Institutes, etc.)
• 8.4. Market Attractiveness Analysis, by End-user

9. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region, 2020-2034
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast

• 10.1. Introduction
• 10.2. Key Findings
• 10.3. Market Value Forecast, by Test Type, 2020-2034
  • 10.3.1. Glucose
  • 10.3.2. Calcium
  • 10.3.3. Electrolytes
  • 10.3.4. Kidney Function Tests
  • 10.3.5. Liver Function Tests
  • 10.3.6. Others (Protein, etc.)
• 10.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 10.4.1. Kidney Diseases
  • 10.4.2. Liver Diseases
  • 10.4.3. Diabetes
  • 10.4.4. Others (Hypertension, etc.)
• 10.5. Market Value Forecast, by End-user, 2020-2034
  • 10.5.1. Hospitals & Clinics
  • 10.5.2. Diagnostic Laboratories
  • 10.5.3. Others (Research Institutes, etc.)
• 10.6. Market Value Forecast, by Country, 2020-2034
  • 10.6.1. U.S.
  • 10.6.2. Canada
• 10.7. Market Attractiveness Analysis
  • 10.7.1. By Test Type
  • 10.7.2. By Disease Indication
  • 10.7.3. By End-user
  • 10.7.4. By Country

11. Europe Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast

• 11.1. Introduction
• 11.2. Key Findings
• 11.3. Market Value Forecast, by Test Type, 2020-2034
  • 11.3.1. Glucose
  • 11.3.2. Calcium
  • 11.3.3. Electrolytes
  • 11.3.4. Kidney Function Tests
  • 11.3.5. Liver Function Tests
  • 11.3.6. Others (Protein, etc.)
• 11.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 11.4.1. Kidney Diseases
  • 11.4.2. Liver Diseases
  • 11.4.3. Diabetes
  • 11.4.4. Others (Hypertension, etc.)
• 11.5. Market Value Forecast, by End-user, 2020-2034
  • 11.5.1. Hospitals & Clinics
  • 11.5.2. Diagnostic Laboratories
  • 11.5.3. Others (Research Institutes, etc.)
• 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 11.6.1. Germany
  • 11.6.2. U.K.
  • 11.6.3. France
  • 11.6.4. Italy
  • 11.6.5. Spain
  • 11.6.6. Rest of Europe
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Test Type
  • 11.7.2. By Disease Indication
  • 11.7.3. By End-user
  • 11.7.4. By Country/Sub-region

12. Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast

• 12.1. Introduction
• 12.2. Key Findings
• 12.3. Market Value Forecast, by Test Type, 2020-2034
  • 12.3.1. Glucose
  • 12.3.2. Calcium
  • 12.3.3. Electrolytes
  • 12.3.4. Kidney Function Tests
  • 12.3.5. Liver Function Tests
  • 12.3.6. Others (Protein, etc.)
• 12.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 12.4.1. Kidney Diseases
  • 12.4.2. Liver Diseases
  • 12.4.3. Diabetes
  • 12.4.4. Others (Hypertension, etc.)
• 12.5. Market Value Forecast, by End-user, 2020-2034
  • 12.5.1. Hospitals & Clinics
  • 12.5.2. Diagnostic Laboratories
  • 12.5.3. Others (Research Institutes, etc.)
• 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 12.6.1. China
  • 12.6.2. Japan
  • 12.6.3. India
  • 12.6.4. Australia & New Zealand
  • 12.6.5. Rest of Asia Pacific
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Test Type
  • 12.7.2. By Disease Indication
  • 12.7.3. By End-user
  • 12.7.4. By Country/Sub-region

13. Latin America Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast

• 13.1. Introduction
• 13.2. Key Findings
• 13.3. Market Value Forecast, by Test Type, 2020-2034
  • 13.3.1. Glucose
  • 13.3.2. Calcium
  • 13.3.3. Electrolytes
  • 13.3.4. Kidney Function Tests
  • 13.3.5. Liver Function Tests
  • 13.3.6. Others (Protein, etc.)
• 13.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 13.4.1. Kidney Diseases
  • 13.4.2. Liver Diseases
  • 13.4.3. Diabetes
  • 13.4.4. Others (Hypertension, etc.)
• 13.5. Market Value Forecast, by End-user, 2020-2034
  • 13.5.1. Hospitals & Clinics
  • 13.5.2. Diagnostic Laboratories
  • 13.5.3. Others (Research Institutes, etc.)
• 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 13.6.1. Brazil
  • 13.6.2. Mexico
  • 13.6.3. Rest of Latin America
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Test Type
  • 13.7.2. By Disease Indication
  • 13.7.3. By End-user
  • 13.7.4. By Country/Sub-region

14. Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast

• 14.1. Introduction
• 14.2. Key Findings
• 14.3. Market Value Forecast, by Test Type, 2020-2034
  • 14.3.1. Glucose
  • 14.3.2. Calcium
  • 14.3.3. Electrolytes
  • 14.3.4. Kidney Function Tests
  • 14.3.5. Liver Function Tests
  • 14.3.6. Others (Protein, etc.)
• 14.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 14.4.1. Kidney Diseases
  • 14.4.2. Liver Diseases
  • 14.4.3. Diabetes
  • 14.4.4. Others (Hypertension, etc.)
• 14.5. Market Value Forecast, by End-user, 2020-2034
  • 14.5.1. Hospitals & Clinics
  • 14.5.2. Diagnostic Laboratories
  • 14.5.3. Others (Research Institutes, etc.)
• 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 14.6.1. GCC Countries
  • 14.6.2. South Africa
  • 14.6.3. Rest of Middle East & Africa
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Test Type
  • 14.7.2. By Disease Indication
  • 14.7.3. By End-user
  • 14.7.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
• 15.2. Market Share Analysis, by Company (2023)
• 15.3. Company Profiles
  • 15.3.1. Roche Diagnostics
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Product Portfolio
    • 15.3.1.3. SWOT Analysis
    • 15.3.1.4. Financial Overview
    • 15.3.1.5. Strategic Overview
  • 15.3.2. Scion Lab Services, LLC
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Product Portfolio
    • 15.3.2.3. SWOT Analysis
    • 15.3.2.4. Financial Overview
    • 15.3.2.5. Strategic Overview
  • 15.3.3. Baptist Health
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Product Portfolio
    • 15.3.3.3. SWOT Analysis
    • 15.3.3.4. Financial Overview
    • 15.3.3.5. Strategic Overview
  • 15.3.4. Walk-in Lab, LLC
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Product Portfolio
    • 15.3.4.3. SWOT Analysis
    • 15.3.4.4. Financial Overview
    • 15.3.4.5. Strategic Overview
  • 15.3.5. Testing.com
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Product Portfolio
    • 15.3.5.3. SWOT Analysis
    • 15.3.5.4. Financial Overview
    • 15.3.5.5. Strategic Overview
  • 15.3.6. My Care Labs
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Product Portfolio
    • 15.3.6.3. SWOT Analysis
    • 15.3.6.4. Financial Overview
    • 15.3.6.5. Strategic Overview
  • 15.3.7. ARUP Laboratories
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Product Portfolio
    • 15.3.7.3. SWOT Analysis
    • 15.3.7.4. Financial Overview
    • 15.3.7.5. Strategic Overview
  • 15.3.8. Blueprint Genetics Oy
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Product Portfolio
    • 15.3.8.3. SWOT Analysis
    • 15.3.8.4. Financial Overview
    • 15.3.8.5. Strategic Overview
  • 15.3.9. Applied InGENuity Diagnostics
    • 15.3.9.1. Company Overview
    • 15.3.9.2. Product Portfolio
    • 15.3.9.3. SWOT Analysis
    • 15.3.9.4. Financial Overview
    • 15.3.9.5. Strategic Overview
  • 15.3.10. Quest Diagnostics
    • 15.3.10.1. Company Overview
    • 15.3.10.2. Product Portfolio
    • 15.3.10.3. SWOT Analysis
    • 15.3.10.4. Financial Overview
    • 15.3.10.5. Strategic Overview

관련자료